Comparative Clinical-Imaging and Histogenetic Analysis Between Astrocytoma IDH-Mutant Grade 4 and Glioblastoma IDH-Wildtype—Is There Really a Worse One?
<b>Background:</b> Brain tumors pose a significant health threat, leading to high morbidity and mortality rates. Astrocytoma IDH-mutant grade 4 (A4<sub>IDHmt</sub>) and glioblastoma IDH-wildtype (G4I<sub>DHwt</sub>) exhibit similar clinical and imaging characteris...
Saved in:
| Main Authors: | Cristian Ionut Orasanu, Mariana Aschie, Mariana Deacu, Madalina Bosoteanu, Sorin Vamesu, Manuela Enciu, Georgeta Camelia Cozaru, Anca Florentina Mitroi, Sinziana Andra Ghitoi, Ana Maria Cretu, Oana Andreea Ursica, Raluca Ioana Voda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/4/438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GENETIC BIOMARKERS OF GLIAL BRAIN TUMORS: IDH1 AND IDH2 MUTATIONS
by: M. Yu. Prokudin, et al.
Published: (2020-09-01) -
An Analysis for IDH‐Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice
by: Xianxin Qiu, et al.
Published: (2025-07-01) -
Molecular characteristics of anaplastic astrocytomas and isolation of molecular subgroups of their IDH1 mutant forms using in silico analysis
by: P. V. Nikitin, et al.
Published: (2020-10-01) -
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
by: Liv Cathrine Heggebø, et al.
Published: (2025-01-01) -
Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions
by: Zhenjiang Pan, et al.
Published: (2025-06-01)